PERRI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 291
NA - Nord America 262
AS - Asia 97
AF - Africa 5
SA - Sud America 2
Totale 657
Nazione #
US - Stati Uniti d'America 257
IT - Italia 171
SE - Svezia 68
SG - Singapore 40
CN - Cina 24
IN - India 19
DE - Germania 11
ID - Indonesia 9
BG - Bulgaria 8
FI - Finlandia 6
GB - Regno Unito 6
IE - Irlanda 5
RO - Romania 5
CA - Canada 4
MY - Malesia 3
TG - Togo 3
MK - Macedonia 2
SC - Seychelles 2
UA - Ucraina 2
AR - Argentina 1
BE - Belgio 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
MX - Messico 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 657
Città #
Rome 66
Chandler 42
Ashburn 25
Singapore 25
Fairfield 21
Milan 16
New York 11
San Paolo di Civitate 11
Padova 9
Princeton 9
Stockholm 9
Woodbridge 9
Jakarta 8
Lawrence 8
Seattle 8
Sofia 8
Wilmington 8
Houston 6
Millbury 6
Boardman 5
Dublin 5
London 5
Ann Arbor 4
Beijing 4
Cambridge 4
Helsinki 4
Porto Recanati 4
San Diego 4
San Mateo 4
Santa Clara 4
Chapel Hill 3
Delhi 3
Fremont 3
Hebei 3
Lidköping 3
Lomé 3
Los Angeles 3
Naples 3
Shanghai 3
Toronto 3
Andover 2
Arielli 2
Bologna 2
Boston 2
Bühl 2
Floridia 2
Fuzhou 2
Guangzhou 2
Lappeenranta 2
Mahé 2
Baoding 1
Bari 1
Beograd 1
Brno 1
Brussels 1
Caserta 1
Cecina 1
Colle Di Val D'elsa 1
Federal 1
Frankfurt am Main 1
Genova 1
Grafing 1
Grossostheim 1
Hangzhou 1
Hyderabad 1
Kilburn 1
Latina 1
Manila 1
Mannheim 1
Mexico City 1
Mountain View 1
New Delhi 1
Norwalk 1
Nuremberg 1
Ottawa 1
Redwood City 1
Riyadh 1
Romola 1
Sabaudia 1
Sacramento 1
Suyicun 1
São Paulo 1
Teramo 1
Thalmassing 1
Treviso 1
Varese 1
Totale 438
Nome #
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 79
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 74
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 74
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 72
X Seminar- PhD day. Science for Democracy- Democracy for Science. PhD day Infectious Diseases, Microbiology and Public Health. Istituto Superiore di Sanità. 67
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 67
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 67
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease 63
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia 58
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine 49
Evaluation of BAFF, APRIL and CD40L in ocrelizumab-treated pwMS and infectious risk 30
Totale 700
Categoria #
all - tutte 2.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 3 6 3 3
2020/202159 3 10 0 2 1 12 1 5 5 9 3 8
2021/2022183 4 2 27 15 20 10 27 13 15 5 36 9
2022/2023199 22 38 23 14 17 22 11 20 18 0 10 4
2023/2024171 5 10 3 27 18 28 3 21 1 22 12 21
2024/202573 7 9 17 29 11 0 0 0 0 0 0 0
Totale 700